Issues related to pharmaceutical patents.
2025 · 1st Quarter (Jan 1 - Mar 31)
THE ERISA INDUSTRY COMMITTEE
Filed by MEHLMAN CONSULTING, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Termination
- Posted
- Mar 17, 2025
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- MEHLMAN CONSULTING, INC.
- Filing UUID
- 3e4a5861-3ca9-4aa6-afed-4db00c3323d0
- Termination date
- Feb 28, 2025
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.